243 related articles for article (PubMed ID: 17481566)
1. Isolation and enrichment of human genomic CpG islands by methylation-sensitive mirror orientation selection.
Huang Q; Baum L; Huang JF; You JP; Wang F; Wang J; Zheng J; Yan XC; Xia H; Zhao YH; Kuang H; Fu WL
Anal Biochem; 2007 Jun; 365(2):153-64. PubMed ID: 17481566
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q.
Yamada Y; Watanabe H; Miura F; Soejima H; Uchiyama M; Iwasaka T; Mukai T; Sakaki Y; Ito T
Genome Res; 2004 Feb; 14(2):247-66. PubMed ID: 14762061
[TBL] [Abstract][Full Text] [Related]
3. Massive parallel bisulfite sequencing of CG-rich DNA fragments reveals that methylation of many X-chromosomal CpG islands in female blood DNA is incomplete.
Zeschnigk M; Martin M; Betzl G; Kalbe A; Sirsch C; Buiting K; Gross S; Fritzilas E; Frey B; Rahmann S; Horsthemke B
Hum Mol Genet; 2009 Apr; 18(8):1439-48. PubMed ID: 19223391
[TBL] [Abstract][Full Text] [Related]
4. Identification of PRTFDC1 silencing and aberrant promoter methylation of GPR150, ITGA8 and HOXD11 in ovarian cancers.
Cai LY; Abe M; Izumi S; Imura M; Yasugi T; Ushijima T
Life Sci; 2007 Mar; 80(16):1458-65. PubMed ID: 17303177
[TBL] [Abstract][Full Text] [Related]
5. Identification of 27 5' CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers.
Hagihara A; Miyamoto K; Furuta J; Hiraoka N; Wakazono K; Seki S; Fukushima S; Tsao MS; Sugimura T; Ushijima T
Oncogene; 2004 Nov; 23(53):8705-10. PubMed ID: 15467763
[TBL] [Abstract][Full Text] [Related]
6. Features and trend of loss of promoter-associated CpG islands in the human and mouse genomes.
Jiang C; Han L; Su B; Li WH; Zhao Z
Mol Biol Evol; 2007 Sep; 24(9):1991-2000. PubMed ID: 17591602
[TBL] [Abstract][Full Text] [Related]
7. Fidelity of the methylation pattern and its variation in the genome.
Ushijima T; Watanabe N; Okochi E; Kaneda A; Sugimura T; Miyamoto K
Genome Res; 2003 May; 13(5):868-74. PubMed ID: 12727906
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells.
Tryndyak V; Kovalchuk O; Pogribny IP
Anal Biochem; 2006 Sep; 356(2):202-7. PubMed ID: 16824473
[TBL] [Abstract][Full Text] [Related]
9. A NotI-EcoRV promoter library for studies of genetic and epigenetic alterations in mouse models of human malignancies.
Yu L; Liu C; Bennett K; Wu YZ; Dai Z; Vandeusen J; Opavsky R; Raval A; Trikha P; Rodriguez B; Becknell B; Mao C; Lee S; Davuluri RV; Leone G; Van den Veyver IB; Caligiuri MA; Plass C
Genomics; 2004 Oct; 84(4):647-60. PubMed ID: 15475242
[TBL] [Abstract][Full Text] [Related]
10. CpGcluster: a distance-based algorithm for CpG-island detection.
Hackenberg M; Previti C; Luque-Escamilla PL; Carpena P; MartÃnez-Aroza J; Oliver JL
BMC Bioinformatics; 2006 Oct; 7():446. PubMed ID: 17038168
[TBL] [Abstract][Full Text] [Related]
11. Silencing of Peroxiredoxin 2 and aberrant methylation of 33 CpG islands in putative promoter regions in human malignant melanomas.
Furuta J; Nobeyama Y; Umebayashi Y; Otsuka F; Kikuchi K; Ushijima T
Cancer Res; 2006 Jun; 66(12):6080-6. PubMed ID: 16778180
[TBL] [Abstract][Full Text] [Related]
12. Techniques used in studies of age-related DNA methylation changes.
Wojdacz TK; Hansen LL
Ann N Y Acad Sci; 2006 May; 1067():479-87. PubMed ID: 16804030
[TBL] [Abstract][Full Text] [Related]
13. CpG islands--'a rough guide'.
Illingworth RS; Bird AP
FEBS Lett; 2009 Jun; 583(11):1713-20. PubMed ID: 19376112
[TBL] [Abstract][Full Text] [Related]
14. Microarray-based DNA methylation profiling: technology and applications.
Schumacher A; Kapranov P; Kaminsky Z; Flanagan J; Assadzadeh A; Yau P; Virtanen C; Winegarden N; Cheng J; Gingeras T; Petronis A
Nucleic Acids Res; 2006; 34(2):528-42. PubMed ID: 16428248
[TBL] [Abstract][Full Text] [Related]
15. Methylation-sensitive representational difference analysis (MS-RDA).
Ushijima T; Yamashita S
Methods Mol Biol; 2009; 507():117-30. PubMed ID: 18987811
[TBL] [Abstract][Full Text] [Related]
16. Decreased fidelity in replicating CpG methylation patterns in cancer cells.
Ushijima T; Watanabe N; Shimizu K; Miyamoto K; Sugimura T; Kaneda A
Cancer Res; 2005 Jan; 65(1):11-7. PubMed ID: 15665274
[TBL] [Abstract][Full Text] [Related]
17. Distribution of DNA methylation, CpGs, and CpG islands in human isochores.
Varriale A; Bernardi G
Genomics; 2010 Jan; 95(1):25-8. PubMed ID: 19800400
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease.
Jeziorska DM; Murray RJS; De Gobbi M; Gaentzsch R; Garrick D; Ayyub H; Chen T; Li E; Telenius J; Lynch M; Graham B; Smith AJH; Lund JN; Hughes JR; Higgs DR; Tufarelli C
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):E7526-E7535. PubMed ID: 28827334
[TBL] [Abstract][Full Text] [Related]
20. DNA motifs associated with aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Genomics; 2006 May; 87(5):572-9. PubMed ID: 16487676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
